Pyxis Oncology Stock Filter Stocks by Fundamentals
| PYXS Stock | USD 2.01 0.18 9.84% |
Pyxis Oncology fundamentals help investors to digest information that contributes to Pyxis Oncology's financial success or failures. It also enables traders to predict the movement of Pyxis Stock. The fundamental analysis module provides a way to measure Pyxis Oncology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pyxis Oncology stock.
Pyxis | Shares Owned by Institutions |
Pyxis Oncology ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pyxis Oncology's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pyxis Oncology's managers, analysts, and investors.Environmental | Governance | Social |
Pyxis Oncology Institutional Holders
Institutional Holdings refers to the ownership stake in Pyxis Oncology that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pyxis Oncology's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pyxis Oncology's value.| Shares | Perceptive Advisors Llc | 2024-09-30 | 508.5 K | 683 Capital Management Llc | 2024-09-30 | 414.7 K | Northern Trust Corp | 2024-09-30 | 394 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 382.8 K | Hillhouse Capital Advisors, Ltd. | 2024-09-30 | 382.6 K | Decheng Capital Llc | 2024-06-30 | 326.8 K | Bank Of New York Mellon Corp | 2024-06-30 | 311.6 K | Boothbay Fund Management, Llc | 2024-09-30 | 283.6 K | Citadel Advisors Llc | 2024-09-30 | 276 K | Deep Track Capital, Lp | 2024-09-30 | 4.2 M | Laurion Capital Management Lp | 2024-09-30 | 3.6 M |
Pyxis Fundamentals
| Return On Equity | -0.39 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (3.99) % | ||||
| Current Valuation | (4.75 M) | ||||
| Shares Outstanding | 59.47 M | ||||
| Shares Owned By Insiders | 24.54 % | ||||
| Shares Owned By Institutions | 54.50 % | ||||
| Number Of Shares Shorted | 5.84 M | ||||
| Price To Book | 0.78 X | ||||
| Price To Sales | 7.40 X | ||||
| EBITDA | (78.49 M) | ||||
| Net Income | (73.79 M) | ||||
| Cash And Equivalents | 223.36 M | ||||
| Cash Per Share | 7.48 X | ||||
| Total Debt | 21.33 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 15.19 X | ||||
| Book Value Per Share | 2.58 X | ||||
| Cash Flow From Operations | (70.71 M) | ||||
| Short Ratio | 8.24 X | ||||
| Earnings Per Share | (1.06) X | ||||
| Price To Earnings To Growth | 0.01 X | ||||
| Target Price | 10.67 | ||||
| Number Of Employees | 54 | ||||
| Beta | 1.28 | ||||
| Market Capitalization | 119.53 M | ||||
| Total Asset | 173.73 M | ||||
| Retained Earnings | (286.23 M) | ||||
| Working Capital | 98.84 M | ||||
| Net Asset | 173.73 M |
About Pyxis Oncology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pyxis Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pyxis Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pyxis Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pyxis Stock Analysis
When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.